Watershed Private Wealth’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$393K Hold
2,509
0.11% 94
2026
Q1
$383K Sell
2,509
-156
-6% -$23.9K 0.12% 87
2025
Q4
$367K Hold
2,665
0.11% 91
2025
Q3
$342K Hold
2,665
0.11% 88
2025
Q2
$322K Sell
2,665
-265
-9% -$29.9K 0.12% 84
2025
Q1
$327K Buy
+2,930
New +$312K 0.13% 89
2024
Q4
Sell
-1,989
Closed -$229K 117
2024
Q3
$229K Hold
1,989
0.09% 103
2024
Q2
$212K Sell
1,989
-187
-9% -$18.8K 0.09% 108
2024
Q1
$210K Sell
2,176
-235
-10% -$24.1K 0.09% 120
2023
Q4
$243K Buy
+2,411
New +$233K 0.13% 94

Other funds holding NVS

Watershed Private Wealth's NVS Position: Q2 2026 in Review

Watershed Private Wealth held its Novartis (NVS) position steady in Q2 2026 at 2,509 shares worth $393K. The position accounts for 0.11% of the portfolio, ranked #94.

Watershed Private Wealth first reported a position in NVS in Q4 2023 and has held it in 10 quarters since. 1,610 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Watershed Private Wealth held 2,509 shares of Novartis worth $393K as of Q2 2026.
  • Watershed Private Wealth left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.11% of Watershed Private Wealth's portfolio in Q2 2026, its #94 holding.
  • Watershed Private Wealth first reported a position in Novartis in Q4 2023 and has held it in 10 quarters since.
  • 1,610 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Watershed Private Wealth's 13F filing for Q2 2026, filed 17 Jul 2026.